4/23
09:03 pm
axsm
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Jacobson Mark L.
Low
Report
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Jacobson Mark L.
4/23
09:02 pm
axsm
Form 4 Axsome Therapeutics, For: Apr 22 Filed by: Maizel Ari
Low
Report
Form 4 Axsome Therapeutics, For: Apr 22 Filed by: Maizel Ari
4/23
09:02 pm
axsm
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: TABUTEAU HERRIOT
Low
Report
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: TABUTEAU HERRIOT
4/23
09:01 pm
axsm
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Maizel Ari
Low
Report
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Maizel Ari
4/23
09:01 pm
axsm
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Pizzie Nick
Low
Report
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Pizzie Nick
4/23
09:00 pm
axsm
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Murdock Hunter R.
Low
Report
Form 4 Axsome Therapeutics, For: Apr 21 Filed by: Murdock Hunter R.
4/22
04:04 pm
axsm
Form 144 Axsome Therapeutics, Filed by: Maizel Ari
Low
Report
Form 144 Axsome Therapeutics, Filed by: Maizel Ari
4/1
07:05 am
axsm
Form 8-K Axsome Therapeutics, For: Apr 01
Low
Report
Form 8-K Axsome Therapeutics, For: Apr 01
3/26
04:11 pm
axsm
Form SCHEDULE 13G/A Axsome Therapeutics, Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A Axsome Therapeutics, Filed by: VANGUARD GROUP INC
2/27
07:10 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Murdock Hunter R.
Low
Report
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Murdock Hunter R.
2/27
07:10 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Maizel Ari
Low
Report
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Maizel Ari
2/27
07:10 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Pizzie Nick
Low
Report
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Pizzie Nick
2/27
07:10 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Jacobson Mark L.
Low
Report
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Jacobson Mark L.
2/27
07:10 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: TABUTEAU HERRIOT
Low
Report
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: TABUTEAU HERRIOT
2/27
07:00 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Coleman Mark
Low
Report
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Coleman Mark
2/27
07:00 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Jacobson Mark L.
Low
Report
Form 4 Axsome Therapeutics, For: Feb 26 Filed by: Jacobson Mark L.
2/26
04:53 pm
axsm
Form 144 Axsome Therapeutics, Filed by: Jacobson Mark L.
Low
Report
Form 144 Axsome Therapeutics, Filed by: Jacobson Mark L.
2/26
04:29 pm
axsm
Form 144 Axsome Therapeutics, Filed by: Coleman Mark
Low
Report
Form 144 Axsome Therapeutics, Filed by: Coleman Mark
2/25
07:00 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 23 Filed by: Coleman Mark
Low
Report
Form 4 Axsome Therapeutics, For: Feb 23 Filed by: Coleman Mark
2/23
07:23 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 20 Filed by: Coleman Mark
Low
Report
Form 4 Axsome Therapeutics, For: Feb 20 Filed by: Coleman Mark
2/23
05:03 pm
axsm
Form 10-K Axsome Therapeutics, For: Dec 31
Medium
Report
Form 10-K Axsome Therapeutics, For: Dec 31
2/23
07:18 am
axsm
Form 8-K Axsome Therapeutics, For: Feb 23
Low
Report
Form 8-K Axsome Therapeutics, For: Feb 23
2/17
07:06 am
axsm
Form 8-K Axsome Therapeutics, For: Feb 17
Low
Report
Form 8-K Axsome Therapeutics, For: Feb 17
2/10
07:11 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 10 Filed by: Coleman Mark
Low
Report
Form 4 Axsome Therapeutics, For: Feb 10 Filed by: Coleman Mark
2/2
06:30 pm
axsm
Form 4 Axsome Therapeutics, For: Feb 02 Filed by: TABUTEAU HERRIOT
Low
Report
Form 4 Axsome Therapeutics, For: Feb 02 Filed by: TABUTEAU HERRIOT